Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

He has a private jet, a pedigree of winning billion-dollar settlements, and the (sometimes grudging) respect of his adversaries. Now, he wants to become pharma’s latest headache. Class-action attorney Steve Berman is coming after a drug industry he says is “gouging” the American consumer. And his suits have the potential to crack the lid on the… Read the rest of this entry »

• Tweet

Phony Pallone keeps the $10K, Blames EpiPen price gouging on Republicans

Congressman refuses to address the $10K he’s accepted from EpiPen’s PAC

graphic via ShoreNewsNetwork.com

When asked to respond to his challenger’s call for him to return the $10K he’s accepted from Mylan Pharmaceuticals,the manufacturer of EpiPen, the lifesaving emergency treatment for anaphylactic shock, Congressman Frank Pallone blamed the 400% wholesale price increase for the drug on congressional Republicans.

“It’s outrageous that drug companies like Mylan continue to dramatically increase the cost of lifesaving drugs, and this is just the latest example of why Congress needs to tackle the overall problem. I’ve been a longtime and outspoken advocate for Congress and my committee to address this issue, but, unfortunately, the Republican majority has repeatedly refused to work with us to solve this problem. We must find a solution to ensure that American’s aren’t subject to the whims of bad actors in the Bio-Pharmaceutical Industry,” Pallone’s statement to Observer read. (emphasis added)

Read the rest of this entry »

• Tweet

Sonnek-Schelmz Slams “Special Interest Money Addict” Pallone For Accepting EpiPen Cash

Congressman Frank Pallone

Republican congressional candidate Brent Sonnek-Schmelz today demanded that Congressman Frank Pallone (Radical Progressive Liberal Democrat-Middlesex and Monmouth Counties) return the $10,000 he has collected from Mylan Pharmaceuticals’ political action committee and that Pallone explain his cozy financial relationships with the companies he is charged with overseeing as the ranking member of the House Energy and Commerce Committee.

Mylan and CEO Heather Bresch have come under scrutiny this week after it was reported that the company has increased the wholesale price of EpiPen 400% while Bresch’s salary has increased 671% from $2,453,456 in 2007, the year of the Mylan aquired EpiPen to $18,931,068 in 2015.

EpiPen is a life saving emergency treatment for anaphylactic shock.  Sales of the drug provide 40% of Mylan’s operating profit, according to published reports.

Read the rest of this entry »

• Tweet